New American Cites ACSH As Counterpoint To Big Pharma On Harm Reduction

By ACSH Staff — Aug 20, 2015
At New American, journalist Raven Clabough notes that the pharmaceutical companies behind the lucrative gum and patch nicotine replacement tools used for smoking cessation have been lobbying heavily against competitors such as e-cigarettes. The U.S. Food and Drug Administration has proposed new rules on e-cigarettes, including reviewing new e-cigarette products before they are sold and outlawing sales of the vapor devices to minors, because they have not been properly studied, leaving consumers unaware of potential health effects that could be related to their usage.

At New American, journalist Raven Clabough notes that the pharmaceutical companies behind the lucrative gum and patch nicotine replacement tools used for smoking cessation have been lobbying heavily against competitors such as e-cigarettes.

The U.S. Food and Drug Administration has proposed new rules on e-cigarettes, including reviewing new e-cigarette products before they are sold and outlawing sales of the vapor devices to minors, because they have not been properly studied, leaving consumers unaware of potential health effects that could be related to their usage.

Unfortunately, Clabough then editorializes and says the same is true about genetically modified foods, which actually have been thoroughly studied for decades and used by tens of millions of people and billions of animals without issue. So New American gets it right 50 percent of the time.